Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
This funding opportunity supports innovative bioengineering projects that aim to improve healthcare solutions and research methods, particularly in terms of effectiveness, efficiency, and accessibility.
Description
The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.